A Cardioprotective Role of Nerium oleander with the Expression of Hypoxia Inducible Factor 2A mRNA by Increasing Antioxidant Enzymes in Rat Heart Tissue

Mustafa Hitit, Orhan Corum, Duygu Durna Corum, Huseyin Donmez, Gul Cetin, Burak Dik, Ayse Er

Abstract


Background: Nerium oleander (NO) distillate is used to either protect heart cells against oxidative stress or reduce the risk of cardiovascular disease by regulating the production of reactive oxygen species. Hypoxia-inducible factors (HIFs) regulate cellular antioxidant defense mechanisms under hypoxic conditions in which heart cells survive; however, the key responsible mechanism of NO distillate for cardioprotection remains elusive. The objective of this study was to evaluate the effects on heart tissue at different time intervals after administering NO distillate
intraperitoneally (IP) while considering the transcriptional regulation of HIFs and representative antioxidant enzymes.

Materials, Methods & Results: The NO plant was chopped, and distillated water was added. The mixture was distilled, and the distillate separated and collected into tubes, after which it was lyophilized to obtain dry material. Twenty male Wistar albino rats (2-3 month-old, 250-300 g
each) were used in the study. The rats were randomly divided into four groups. The control group (n = 5) received IP injections of saline; the remaining 15 rats received IP injections of a single dose of 7.5 mL NO distillate. The NO distillate injected rats were divided into three groups
according to the time from injection to harvest the heart tissue samples. The tissues were collected at 0 h (control; n = 5), 2 h (group 2; n = 5), 4 h (group 3; n = 5), and 8 h (group 4; n = 5) after injection and under general anesthesia (60 mg/kg ketamine, IP + 10 mg/kg xylazine, IP).
Quantitative polymerase chain reaction (qPCR) was used to assess the expression profiles of the genes of interest in the heart tissues. Hypoxanthine phosphoribosyltransferase was used as the reference gene. The expression of manganese superoxide dismutase (MnSOD) mRNA was in a steady state level between the control group and group 2 (P > 0.05); however, it significantly increased in group 3 and 4 compared with that in the control (P < 0.05). Expression of catalase (CAT) mRNA was significantly higher in group 2 than in the control group (P < 0.05) although it was lower in group 3 and 4 than in group 2 (P < 0.05); however, it appeared to be similar among the control group, group 3, and group 4 (P > 0.05). Copper (Cu) SOD mRNA was equally
expressed in both the control group and group 2 (P > 0.05) but was lower in group 3 and 4 than in group 2 (P < 0.05). Expressions of HIF1A, HIF2A, and HIF3A mRNA were detected in the rat heart tissues in the control and 2, 4, and 8 h after administration of NO distillate. Expression of
HIF1A mRNA was in a steady state and did not differ among groups 2, 3, and 4 (P > 0.05). Similarly, the expression of HIF2A mRNA did not change between the control group and group 2 (P > 0.05); however, it was higher in group 3 than in the control (P < 0.05) and tended to be
higher in group 3 than in group 2 (P = 0.063). HIF3A mRNA expression did not change significantly in the heart tissue of any of the groups (P > 0.05).

Discussion: The present study using rats determined that MnSOD, CAT, CuSOD, HIF1A, HIF2A, and HIF3A mRNA are expressed in the heart tissues after administration of NO distillate. The increased expression of HIF2A mRNA after 4 h in accordance with a rise in CAT mRNA after 2 h, and MnSOD mRNA after 4 and 8 h might confirm the role of HIF2A mRNA in oxidative stress defense by regulating antioxidant enzymes; consequently, this study may expand our understanding of uses of NO distillate with respect to molecular pathways.


Full Text:

PDF

References


Alameddine F.M & Zafari A.M. 2002. Genetic polymorphisms and oxidative stress in heart failure. Congestive Heart Failure. 8(3):157-164.

Ayaz M., Baba F., Akgun N., Bas A.L., Uney K. & Dik B. 2015. Protective effect of distillated Nerium oleander on heart of type 2 diabetic rats. Bratislavské lekárske listy. 116(7): 451-6.

Bas A.L., Demirci S, Yazihan N., Uney K. & Ermis K.E. 2012. Nerium oleander distillate improves fat and glucose metabolism in high-fat diet-fed streptozotocin-induced diabetic rats. International Journal of Endocrinology. 201(2): 947187.

Braunwald E. 1999. 50th anniversary historical article. Myocardial oxygen consumption: the quest for its determinants and some clinical fallout. Journal of the American College of Cardiology. 34(5): 1365-1368.

Corno A.F., Milano G., Samaja M., Tozzi P. & von Segesser L.K. 2002. Chronic hypoxia: a model for cyanotic congenital heart defects. The Journal of Thoracic and Cardiovascular Surgery. 124(1): 105-112.

Dieterich S., Bieligk U., Beulich K., Hasenfuss G. & Prestle J. 2000. Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart. Circulation. 101(1): 33-39.

Er A., Corum O., Cetin G. & Dik B. 2015. Nerium oleander distilatı uygulamasının serum nitrik oksit düzeyine etkisi. Eurasian Journal of Veterinary Sciences. 31(2): 70-74.

Essop M.F. 2007. Cardiac metabolic adaptations in response to chronic hypoxia. The Journal of Physiology. 584(Pt 3):715-726.

Gayathri V., Ananthi S., Chandronitha C., Ramakrishnan G., Lakshmisundaram R. & Vasanthi H.R. 2011. Cardioprotective effect of Nerium oleander flower against isoproterenol-induced myocardial oxidative stress in experimental rats. Journal of Cardiovascular Pharmacology and Therapeutics. 16(1): 96-104.

Heidbreder M., Fröhlich F., Jöhren O., Dendorfer A., Qadri F. & Dominiak P. 2003. Hypoxia rapidly activates HIF-3alpha mRNA expression. Federation of American Societies for Experimental Biology. 17(11): 1541-1543.

Hitit M. & Guzeloglu A. 2016. Investigation of liver X receptor pathway in luteal regression. Reproduction in Domestic Animals 51(S2): 63-64.

Jaakkola P., Mole D.R., Tian Y.M, Wilson M.I., Gielbert J., Gaskell S.J., von Kriegsheim A., Hebestreit H.F., Mukherji M., Schofield C.J., Maxwell P.H., Pugh C.W. & Ratcliffe P.J. 2001. Targeting of HIF- to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 292(5516): 468-472.

Jain S., Maltepe E., Lu M.M., Simon C. & Bradfield C.A. 1998. Expression of ARNT, ARNT2, Hif1 alpha, Hif2 alpha and AH receptor mRNAs in the developing mouse. Mechanisms of Development. 73(1): 117-123.

Jiang B.H., Rue E., Wang G.L., Roe R. & Semenza G.L. 1996. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. The Journal of Biological Chemistry. 271(30): 17771-17778.

Jürgensen J.S., Rosenberger C., Wiesener M.S., Warnecke C., Hörstrup J.H., Gräfe M., Philipp S., Griethe W., Maxwell P.H., Frei U., Bachmann S., Willenbrock R., & Eckardt K.U. 2004. Persistent induction of HIF-1αand -2αin cardiomyocytes and stromal cells of ischemic myocardium. Federation of American Societies for Experimental Biology. 18(12): 1415-1417.

Kaelin WG. Jr. 2011. Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases. Cold Spring Harbor Symposia on Quantitative Biology. 76: 335-345.

Kaewpila S., Venkataraman S., Buettner G.R. & Oberley L.W. 2008. Manganese Superoxide Dismutase Modulates Hypoxia- Inducible Factor-1α Induction via Superoxide. Cancer Research. 68(8): 2781-2788.

Kasparova D., Neckar J., Dabrowska L., Novotny J., Mraz J., Kolar F. & Zurmanova J. 2015. Cardioprotective and nonprotective regimens of chronic hypoxia diversely affect the myocardial antioxidant systems. Physiological Genomics. 47(12): 612-620.

Kiran C. & Prasad D. N. 2014. A review on: Nerium oleander Linn. (Kaner). International Journal of Pharmacognosy and Phytochemical Research. 6(3): 593-597.

Kojima I., Tanaka T., Inagi R., Kato H., Yamashita T., Sakiyama A., Ohneda O., Takeda N., Sata M., Miyata T., Fujita T. & Nangaku M. 2007. Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney. Journal of the American Society of Nephrology. 18(4): 1218-1226.

Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C. & Epstein C.J. 1995. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genetics. 11(4): 376-381.

Livak K.J. & Schmittgen T.D. 2001. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25: 402-408.

Martin C., Yu A.Y., Jiang B.H., Davis L., Kimberly D., Hohimer A.R. & Semenza G.L. 1998. Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. American Journal of Obstetrics & Gynecology. 178(3): 527-34.

Mohadjerani M. 2012. Antioxidant Activity and Total Phenolic Content of Nerium oleander L. Grown in North of Iran. Iranian Journal of Pharmaceutical Research. 11(4): 1121-6.

Nanayakkara G., Alasmari A., Mouli S., Eldoumani H., Quindry J., McGinnis G., Fu X., Berlin A., Peters B., Zhong J. & Amin R. 2015. Cardioprotective HIF-1α-frataxin signaling against ischemia-reperfusion injury. American Journal of Physiology-Heart and Circulatory Physiology. 309(5): H867-879.

Nojiri H., Shimizu T., Funakoshi M., Yamaguchi O., Zhou H., Kawakami S., Ohta Y., Sami M., Tachibana T., Ishikawa H., Kurosawa H., Kahn RC., Otsu K. & Shirasawa T. 2006. Oxidative stress causes heart failure with impaired mitochondrial respiration. The Journal of Biological Chemistry. 281(44): 33789-33801.

Patterson A.J. & Zhang L. 2010. Hypoxia and fetal heart development. Current Molecular Medicine. 10(7): 653-666.

Reuland D.J., McCord J.M. & Hamilton K.L. 2013. The role of Nrf2 in the attenuation of cardiovascular disease. Exercise and Sport Sciences Reviews. 41(3): 162-168.

Robador P.A., San Jose G., Rodriguez C., Guadall A., Moreno M.U., Beaumont J., Fortuño A., Díez J., Martínez-González J. & Zalba G. 2011. HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia. Cardiovascular Research. 92(2): 247-255.

Rodrigo R., Prieto J.C. & Castillo R. 2013. Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n− 3 fatty acids: molecular mechanisms and potential clinical applications. Clinical Science. 124(1): 1-15.

Sam F., Kerstetter D.L., Pimental D.R., Mulukutla S. Tabaee A., Bristow M.R., Colucci W.S. & Sawyer D.B. 2005. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. Journal of Cardiac Failure. 11(6): 473-480.

Semenza G.L. 2003. Targeting HIF-1 for cancer therapy. Nature Reviews Cancer. 3(10): 721-732.

Semenza G.L. 2014. Hypoxia-inducible factor 1 and cardiovascular disease. Annual Review of Physiology. 76: 39-56.

Singhal K.G. & Gupta G.D. 2012. Hepatoprotective and antioxidant activity of methanolic extract of flowers of Nerium oleander against CCl4-induced liver injury in rats. Asian Pacific Journal of Tropical Medicine. 5(9): 677-685.

Souiden Y., Mallouli H., Meskhi S., Chaabouni Y., Rebai A., Chéour F. & Mahdouani K. 2016. MnSOD and GPx1 polymorphism relationship with coronary heart disease risk and severity. Biological Research. 49: 22.

Tekin D., Dursun A.D. & Xi L. 2010. Hypoxia inducible factor 1 (HIF-1) and cardioprotection. Acta Pharmacologica Sinica. 31(9): 1085-1094.

Wang G.L., Jiang B.H., Rue E.A. & Semenza G.L. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences of the United States of America. 92(12): 5510-5514.

Wang J., Lin F., Guo L., Xiong X. & Fan X. 2015. Cardiovascular Disease, Mitochondria, and Traditional Chinese Medicine. Evidence-based Complementary and Alternative Medicine. 12: 1-7.

Wang Z. & Si L.Y. 2013. Hypoxia-inducible factor-1α and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats. Upsala Journal of Medical Sciences. 118(2): 65-74.

Wiesener M.S, Jurgensen J.S., Rosenberger C., Scholze C.K., Horstrup J.H., Warnecke C., Mandriota S., Bechmann I., Frei U.A, Pugh C.W, Ratcliffe P.J., Bachmann S., Maxwell P.H. & Eckardt K.U. 2003. Widespread hypoxia-inducible expression of Hif-2alpha in distinct cell populations of different organs. Widespread hypoxia-inducible expression of Hif-2alpha in distinct cell populations of different organs. FASEB J. 17(2): 271-273.

Wu J., Chen P., Li Y., Ardell C., Der T., Shohet R., Chen M. & Wright G.L. 2013. HIF-1α in heart: Protective mechanisms. American Journal of Physiology. Heart and Circulatory Physiology. 305(6): H821-H828.

Yamashita T., Ohneda O., Nagano M., Iemitsu M., Makino Y., Tanaka H., Miyauchi T., Goto K., Ohneda K., Fujii-Kuriyama Y., Poellinger L. & Yamamoto M. 2008. Abnormal heart development and lung remodeling in mice lacking the hypoxia-inducible factor-related basic helix-loop-helix PAS protein NEPAS. Molecular and Cellular Biology. 28(4): 1285-1297.

Yeh C.T., Ching L.C. & Yen G.C. 2009. Inducing gene expression of cardiac antioxidant enzymes by dietary phenolic acids in rats. The Journal of Nutritional Biochemistry. 20(3): 163-171.

Yin H.L., Luo C.W., Dai Z.K., Shaw K.P., Chai C.Y. & Wu C.C. 2016. Hypoxia-inducible factor-1α, vascular endothelial growth factor, inducible nitric oxide synthase, and endothelin-1 expression correlates with angiogenesis in congenital heart disease. The Kaohsiung Journal of Medical Sciences. 32(7): 348-355.

Yoshida T., Maulik N., Engelman R.M., Ho Y.S. & Das D.K. 2000. Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circulation Research. 86: 264-269.




DOI: https://doi.org/10.22456/1679-9216.82557

Copyright (c) 2018 Mustafa Hitit, Orhan Corum, Duygu Durna Corum, Huseyin Donmez, Gul Cetin, Burak Dik, Ayse Er

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.